Skip to content
20-F

Annual Report (Foreign)

MOLECULAR PARTNERS AG MOLN

0001745114-25-000009

← back to feed
Filed
Mar 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 31, 2024 40.36M sh
Revenue FY 2024 · Dec 31, 2024 4.97M
Revenue FY 2024 · Dec 31, 2023 7.04M
Revenue FY 2024 · Dec 31, 2022 189.6M
Current Liabilities FY 2024 · Dec 31, 2023 14.42M
Total Liabilities FY 2024 · Dec 31, 2023 21.92M
Current Assets FY 2024 · Dec 31, 2023 192.46M
Total Assets FY 2024 · Dec 31, 2023 198.35M
Shares Diluted FY 2024 · Dec 31, 2022 32.47M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 118.57M
Eps Diluted FY 2024 · Dec 31, 2022 3.54
Eps Basic FY 2024 · Dec 31, 2022 3.63
Sga Expense FY 2024 · Dec 31, 2022 22.24M
Rd Expense FY 2024 · Dec 31, 2022 50.75M
Net Income FY 2024 · Dec 31, 2022 117.85M
Operating Income FY 2024 · Dec 31, 2022 116.61M
Cash And Equivalents FY 2024 · Dec 31, 2021 71.81M
Stockholders Equity FY 2024 · Dec 31, 2021 107.29M